RHC - Ramsay Health Care Limited
ASX
->
Healthcare
->
Medical Care Facilities
Sydney,
Australia
Type: Equity
RHC price evolution
RHC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $662.3 | $0.02 | $361.7 | |
| Short term investments | ||||
| Net receivables | $2522.6 | $0.47 | $2451.6 | |
| Inventory | $379.4 | $379.4 | $383.9 | |
| Total current assets | $3872.8 | $1.7 | $3498.4 | |
| Long term investments | $17.6 | $17.6 | $6.1 | |
| Property, plant & equipment | $10159 | $86.44 | $10274.9 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $20894 | $88.24 | $20638.1 | |
| Current liabilities | ||||
| Accounts payable | $1651.8 | $4 | $2966 | |
| Deferred revenue | ||||
| Short long term debt | $605.8 | $605.8 | $513.5 | |
| Total current liabilities | $4180.3 | $9.14 | $3676.1 | |
| Long term debt | $10336.1 | $32.22 | $10596.8 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $15366.5 | $42.03 | $15147.7 | |
| Shareholders' equity | ||||
| Retained earnings | $2500.2 | -$50.63 | $2473.1 | |
| Other shareholder equity | $591.3 | $0.73 | $599.5 | |
| Total shareholder equity | $5527.5 | $5527.5 | $5490.4 | |
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $662.3 | $656.1 | $314.2 | $1004.8 |
| Short term investments | ||||
| Net receivables | $2522.6 | $2315.6 | $2373.5 | $1813.7 |
| Inventory | $379.4 | $388.6 | $376.8 | $409.4 |
| Total current assets | $3872.8 | $3895.8 | $3286.7 | $5351.4 |
| Long term investments | $17.6 | $64.5 | $283.8 | $300.4 |
| Property, plant & equipment | $10159 | $10187.2 | $9434.6 | $8900.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $20894 | $21030.2 | $19473.3 | $19324.6 |
| Current liabilities | ||||
| Accounts payable | $1651.8 | $1484.3 | $1476 | $1164.6 |
| Deferred revenue | ||||
| Short long term debt | $605.8 | $486.8 | $397.6 | $419.9 |
| Total current liabilities | $4180.3 | $3810.4 | $3725.6 | $3717.2 |
| Long term debt | $10336.1 | $11399.5 | $10301.1 | $10131.8 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $15366.5 | $16207 | $14947.1 | $15291.9 |
| Shareholders' equity | ||||
| Retained earnings | $2500.2 | $1786.7 | $1708.7 | $1659.6 |
| Other shareholder equity | $591.3 | $635.7 | $440.1 | $426.8 |
| Total shareholder equity | $5527.5 | $4823.2 | $4526.2 | $4032.7 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.64 | $4291.05 | $0.79 | $4042.55 |
| Cost of revenue | $3765.6 | $3556.85 | ||
| Gross Profit | -$0.6 | $525.45 | -$1.2 | $524.85 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1.69 | $4043.35 | $1.93 | $3820.15 |
| Operating income | $247.7 | $259.25 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $33.65 | |||
| Interest expense | -$1.15 | -$155.25 | -$1.29 | -$156.8 |
| Net income | ||||
| Net income | -$3.44 | $65.1 | -$4.42 | $379.25 |
| Income (for common shares) | $60.75 | $375.25 | ||
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16667.2 | $14963.9 | $13312.4 | $12442.6 |
| Cost of revenue | $14644.9 | $13317.1 | $11903.9 | $3465 |
| Gross Profit | $2022.3 | $1646.8 | $1408.5 | $8977.6 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7817.6 | |||
| Total operating expenses | $15727 | $14303.6 | $12831.5 | $11346.5 |
| Operating income | $940.2 | $660.3 | $480.9 | $1096.1 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $121.3 | $181.5 | $159.3 | $257.8 |
| Interest expense | -$620 | -$514.2 | -$389 | |
| Net income | ||||
| Net income | $888.7 | $298.1 | $274 | $449 |
| Income (for common shares) | $872 | $285.1 | $265 | $439.9 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $65.1 | $379.25 | ||
| Operating activities | ||||
| Depreciation | $251.65 | $263.3 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $542.35 | $104.05 | ||
| Investing activities | ||||
| Capital expenditures | -$176.6 | -$200.3 | ||
| Investments | ||||
| Total cash flows from investing | -$2.65 | -$180.25 | -$2.43 | $260.1 |
| Financing activities | ||||
| Dividends paid | -$41.4 | -$26.05 | ||
| Sale and purchase of stock | ||||
| Net borrowings | -$155.7 | -$482.25 | ||
| Total cash flows from financing | $5.3 | -$205.95 | $1.6 | -$519.1 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.06 | $150.3 | -$2.6 | -$147.2 |
| (in millions $) | 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | $888.7 | $298.1 | $274 | |
| Operating activities | ||||
| Depreciation | $1029.9 | $940.3 | $881.8 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1292.8 | $1279.6 | $715.5 | |
| Investing activities | ||||
| Capital expenditures | -$753.8 | -$720.9 | -$708.5 | |
| Investments | ||||
| Total cash flows from investing | $159.7 | -$713.8 | $30 | -$11.31 |
| Financing activities | ||||
| Dividends paid | -$134.9 | -$218.7 | -$351.9 | |
| Sale and purchase of stock | ||||
| Net borrowings | -$1275.9 | -$3.6 | -$1037.8 | |
| Total cash flows from financing | -$1450.1 | -$242.4 | -$1410.9 | $17.98 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $6.2 | $341.9 | -$690.6 | $4.55 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $8.34B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $436.48M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 2.78 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |